Abstract
Respiratory disorders are common and important complications in acromegaly. Patients suffering from acromegaly display a 1.6–3.3 fold increase in mortality rate, which is due to respiratory disorders in 25% of cases. In these patients, mortality for lung disease is 2–3 fold higher than in the general population. Every portion of the respiratory system may be involved. Deformities of facial bones, edema and hypertrophy of the mucosae and pharyngeal and laryngeal cartilages, enlargement of the tongue and inspiratory collapse of the hypopharinx, all may contribute to respiratory alterations. Nasal polyps, “hormonal rhinitis”, changes of the voice and snoring are common occurrences. Though rarely, a laryngocele may ensue. Pneumomegaly is frequently observed and, as suggested by functional studies, might be due to an increased number rather than volume of the alveoli. An obstructive respiratory syndrome caused by mucosal thickening of the upper airways and bronchi is observed in 25% of female and 70% of male patients. The sleep apnea syndrome (SAS) affects 60–70% of acromegalic patients. SAS may be of obstructive, central or mixed type. Obstructive SAS is the prevailing form in acromegaly. It is due to intermittent obstruction of upper airways with preserved activity of the respiratory center, as testified by the remarkable thoracic and abdominal respiratory efforts. The pathogenesis of the central type of SAS is more complex. Narrowing of the upper airways may induce reflex inhibition of the respiratory center. Moreover, increased GH levels and, possibly, defects in the somatostatinergic pathways, may increase the ventilatory response of the respiratory center to carbon dioxide, thereby leading to respiratory arrest. In the mixed type of SAS, the phenomena underlying the other two forms coexist. Oxygen desaturation concomitant with the apneic episodes accounts for the frequent nocturnal wakening and diurnal drowsiness. Among the clinical correlates of SAS, arterial hypertension is of particular interest due to the close correlation existing between the two disorders. Sleep deprivation related to SAS seems per se to favor the appearance of hypertension. Moreover, short lasting hypoxemia may induce prolonged elevations of blood pressure, mediated by decreased endothelial generation of nitric oxide. Thus, since cardiovascular events are the main cause of mortality in patients with acromegaly, it is reasonable to hypothesize that SAS is involved in the reduced life span of these patients.
Similar content being viewed by others
REFERENCES
Marie P. Sur deux cas d'acromègalie. Rev Med 1886;6:297–333.
Thomas SG, Woodhouse LJ, Pagura SM, Ezzat S. Ventilation threshold as a measure of impaired physical performance in adults with growth hormone excess. Clin Endocrinol 2002;56:351–358.
Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: A retrospective cohort study. J Clin Endocrinol Metab 1998;83:2730–2734.
Evans CC, Hipkin LJ, Murray GM. Pulmonary function in acromegaly. Q J Med 1977;32:322–327.
Grunstein RR, Ho KY, Sullivan CE. Sleep apnoea in acromegaly. Ann Intern Med 1991;115:527–532.
Weiss V, Sonka K, Pretl M, Dostàlova S, Klozar J, Rambousek P, Marek J, Haas T. Prevalence of sieep apnea syndrome in acromegaly population. J Endocrinol Invest 2000;23:515–519.
Lund VJ. International consensus report on the diagnosis and management of rhinitis. Allergy Suppl 1994;19:5–34.
Petruson B, Hansson H, Petruson K. Insulin like growth factor I immunoreactivity in nasal polyps. Arch Otolaryngol Head Neck Surg 1988;114:1272–1275.
Hansson H, Jorgensen F, Petruson B, Petruson K. Regenerating human nasal mucosa cells express peptide growth factors. Arch Otolaryngol Head Neck Surg 1991;117:1368–1377.
Motta S, Ferone D, Colao A, Merola B, Motta G, Lombardi G. Fixity of vocal cords and laryngocele in acromegaly. J Endocrinol Invest 1997;20:672–674.
Pelttari L, Polo O, Rauhala E, Vuoriluoto J, Aitasalo K, Hyyppa T, Kronholm E, Irjala K, Viikari J. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin Endocrinol 1995;43:175–182.
Brody JS, Fisher AB, Gocmen A, DuBois AB. Acromegalic pneumonomegaly: Lung growth in the adult. J Clin Invest 1970;49:1051–1060.
Trotman-Dickenson B, Weetman AP, Hughes JM. Upper airflow obstruction and pulmonary function in acromegaly. Relationship to disease activity. Q J Med 1991;79:527–538.
Pertinen M, Telakivi T. Epidemiology of obstructive sleep apnea syndrome. Sleep 1992;15:1–4.
Bresnitz EA, Goldberg R, Kosinski RM. Epidemiology of obstructive sleep apnea. Epidemiol Rev 1994;16:210–227.
Hochban W, Ehlenz K, Conradt R, Brandenburg U. Obstructive sleep apnoea in acromegaly: The role of craniofacial changes. Eur Resp J 1999;14:196–202.
Isono S, Saeki N, Tanaka A, Nishino T. Collapsibility of passive pharynx in patients with acromegaly. Am J Respir Crit Care Med 1999;160:64–68.
Stevenaert A, Beckeras A. Presurgical octreotide treatment in acromegaly. Acta Endocrinol 1993;129(suppl 1):18–20.
Grunstein RR, Ho KY, Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med 1994;121:478–483.
Douglas N. The sleep apnoea/hypopnoea syndrome and snoring. Br Med J 1993;306:1057–1060.
Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG. Acromegaly: Clinical and biochemical features in 500 patients. Medicine (Baltimore) 1994;73:233–240.
Blankfield RP, Tapolyai AA, Zyzanski SJ. Left ventricular dysfunction, pulmonary hypertension, obesity, and sleep apnea. Sleep Breath 2001;5:57–62.
Kraiczi H, Peker Y, Caidahl K, Samuelsson A, Hender J. Blood pressure, cardiac structure and seventy of obstructive sleep apnea in a sleep clinic population. J Hypertens 2001;11:2071–2078.
Silverberg DS, Iaina A, Oksenberg A.Treating obstructive sleep apnea improves essential hypertension and quality of life. Am Fam Phys 2002;65:229–236.
Guilleminault C, Cummiskey J, Demment W. Sleep apnoea syndrome: Recent advances. Adv Intern Med 1980;26:347–372.
Silverberg DS, Oksenberg A, Radwan H, Iaina A. Is obstructive sleep apnea a common cause of essential hypertension?Isr J Med Sci 1995;31:527–535.
Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: Facts and theory. Am J Med 1995;98:118–128.
Lavie P, Ben-Yosef R, Rubin A. Prevalence of sleep apnea syndrome in patients with essential hypertension. Am Heart J 1984;108:373–376.
Kales A, Bixler EO, Cadieux RJ, Schneck DW, Shaw LC III, Locke TW, Vela-Bueno A, Soldatos CR. Sleep apnoea in a hypertensive population. Lancet 1984;2:1005–1008.
Williams AJ, Houston D, Finberg S, Lam C, Kinney JL, Santiago S. Sleep apnea syndrome and essential hypertension. Am J Cardiol 1985;55:1019–1022.
Fletcher EC, DeBehnke RD, Lovoi MS, Gorin AB. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med1985;103:190–195.
Berger HA, Somers VK, Phillips BG. Sleep disordered breathing and hypertension. Curr Opin Pulm Med 2001;7:386–390.
Tilkian G, Guilleminault C, Schroeder JS. Sleep-induced apnea syndrome: Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977;63:348–355.
Shepard JW Jr, Garrison M, Grither DA, Dolan GF. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985;88:335–340.
He J, Kryger M, Zorick F, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea: Experiences in 385 male patients. Chest 1988;94:9–14.
Rosenow F, Reuter S, Deuss U, Szelies B, Hilgers RD, Winkelmann W, Heiss WD.Sleep apnoea in treated acromegaly: Relative frequency and predisposing factors. Clin Endocrinol 1996;45:563–569.
Rosenow F, McCarthy V, Caruso C. Sleep apnoea in endocrine diseases. J Sleep Res 1998;7:3–11.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fatti, L.M., Scacchi, M., Pincelli, A.I. et al. Prevalence and Pathogenesis of Sleep Apnea and Lung Disease in Acromegaly. Pituitary 4, 259–262 (2001). https://doi.org/10.1023/A:1020702631793
Issue Date:
DOI: https://doi.org/10.1023/A:1020702631793